Value of KL-6 in Rheumatoid Arthritis-Associated ILD

NCT05979454 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 80

Last updated 2023-11-02

No results posted yet for this study

Summary

Evaluation of serum KL6 level in rheumatoid arthritis-associated interstitial lung disease (RA-ILD).

Conditions

  • Rheumatoid Arthritis-Associated Interstitial Lung Disease

Interventions

DIAGNOSTIC_TEST

Krebs von den Lungen-6 (KL6)

KL-6 concentration will be measured using Sandwich ELISA technique (SinoGene Clone Biotech, China).

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Principal Investigators

  • Safaa A Eid, Fellow · Assiut University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2023-12-31
Completion
2023-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05979454 on ClinicalTrials.gov